Abstract
Healthcare-associated infections (HAI) after viral illnesses are important sources of morbidity and mortality. This has not been extensively studied in hospitalized COVID-19 patients. This study included all COVID-19-positive adult patients (≥18 years) hospitalized between 01 March and 05 August 2020 at the current institution. The Centers for Disease Control and Prevention definition of HAI in the acute care setting was used. The outcomes that were studied were rates and types of infections and in-hospital mortality. Several multivariable logistic regression models were constructed to examine characteristics associated with development of HAI. Fifty-nine (3.7%) of 1565 patients developed 140 separate HAIs from 73 different organisms: 23 were Gram-positive, 39 were Gram-negative and 11 were fungal. Patients who developed HAI did not have higher odds of death (OR 0.85, 95% CI 0.40-1.81, p = 0.69). HAIs were associated with the use of tocilizumab (OR 5.04, 95% CI 2.4-10.6, p < 0.001), steroids (OR 3.8, 95% CI 1.4-10, p = 0.007), hydroxychloroquine (OR 3.0, 95% CI 1.0-8.8, p = 0.05), and acute kidney injury requiring hemodialysis (OR 3.7, 95% CI 1.1-12.8, p = 0.04). HAI were common in hospitalized Covid-19 patients. Tocilizum...Continue Reading
References
Jun 10, 2008·American Journal of Infection Control·Teresa C HoranMargaret A Dudeck
Aug 20, 2008·The Journal of Infectious Diseases·David M MorensAnthony S Fauci
Jun 13, 2009·American Journal of Respiratory Cell and Molecular Biology·Lynnelle A PittetAllen G Harmsen
Apr 29, 2011·American Journal of Infection Control·Naomi P O'GradyUNKNOWN Healthcare Infection Control Practices Advisory Committee
Nov 5, 2011·Virology Journal·Amreeta DhanoaGaneswrie Rajasekaram
Dec 1, 2011·Critical Care : the Official Journal of the Critical Care Forum·Hannah MuskettDavid Harrison
Sep 9, 2015·Therapeutics and Clinical Risk Management·Mohamed A HendausAhmed H Alhammadi
Mar 25, 2016·Nature Reviews. Rheumatology·Alexei A GromFabrizio De Benedetti
Sep 13, 2016·Chest·Shipra GuptaKianoush B Kashani
Dec 8, 2016·Scientific Reports·Guang-Ju ZhaoZhong-Qiu Lu
Apr 14, 2017·The Lancet. Gastroenterology & Hepatology·Bastiaan W Haak, W Joost Wiersinga
Jul 18, 2018·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Renyu DingXiaochun Ma
Dec 12, 2018·BMC Infectious Diseases·Chandini Raina MacIntyreAnita Heywood
Jan 27, 2019·Annals of the Rheumatic Diseases·Ajinkya PawarSeoyoung C Kim
Feb 3, 2020·Lancet·Nanshan ChenLi Zhang
Feb 9, 2020·Nature Reviews. Rheumatology·Eva Schrezenmeier, Thomas Dörner
Mar 15, 2020·Lancet·Fei ZhouBin Cao
Apr 14, 2020·International Journal of Rheumatic Diseases·Sanket ShahVir Singh Negi
May 8, 2020·The New England Journal of Medicine·Joshua GelerisNeil W Schluger
May 16, 2020·BMJ : British Medical Journal·Wei TangQing Xie
May 26, 2020·European Journal of Internal Medicine·Valentina MorenaMario Corbellino
Jun 24, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stanley C JordanEdmund Huang
Jul 11, 2020·JAMA : the Journal of the American Medical Association·W Joost WiersingaHallie C Prescott
Jul 12, 2020·The Journal of Infection·Roberto RossottiUNKNOWN Niguarda COVID-19 Working Group
Citations
Mar 16, 2021·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Prachi R PatelAndrea Benin
May 4, 2021·Trends in Microbiology·Lars F WestbladeMichael J Satlin
May 7, 2021·PloS One·Jackson S MusuuzaNasia Safdar
Feb 6, 2021·Mycopathologia·Deepak GargRitesh Agarwal
May 28, 2021·Current Opinion in Infectious Diseases·Madhuri M Sopirala
Sep 3, 2021·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Lindsey M Weiner-LastingerMargaret A Dudeck
Sep 25, 2021·Journal of Medical Virology·Gagan KumarAchuta Kumar Guddati